Qiagen to Work with NCI on siRNA Development …
Qiagen said this week that it has struck a deal with the National Cancer Institute to develop a validated set of siRNAs for use by NCI researchers.
According to the company, the siRNAs will be made available to the general research community after characterization work is complete.
Additional terms of the arrangement were not disclosed.
… And Announces Acqusition of Diagnostics Firm Artus
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
